Having trouble viewing this email? View it as a Web page.

USPTO Alert

USPTO to host virtual panel discussion on the duty of disclosure and duty of reasonable inquiry

Join the United States Patent and Trademark Office (USPTO) on Thursday, February 23, from 3-4 p.m. ET, for a virtual panel discussion on the duty of disclosure and duty of reasonable inquiry. Last July, the USPTO issued a Federal Register notice clarifying these duties, including as to materials or statements material to patentability, or statements made to the USPTO that are inconsistent with statements submitted to the Food & Drug Administration (FDA) and other government agencies.

The panel discussion will be moderated by a patent practitioner, and the panelists will discuss and answer frequently asked questions that the USPTO has received from stakeholders. Send questions in advance to USPTO-FDAcollaboration@uspto.gov.

See a full list of panelists on our website. The event is free and open to all.

For more information, check out the USPTO Director's Blog on duty of disclosure and duty of reasonable inquiry.

​​​

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.